11 Ridiculously Cheap Stocks to Invest in

Page 9 of 9

1. Bausch Health Companies Inc. (NYSE:BHC)

Forward P/E as of April 17: 1.04

Bausch Health Companies Inc. (NYSE:BHC) is a pharmaceutical and medical device company that develops and markets a range of products in the areas of gastroenterology (GI), hepatology, neurology, and dermatology, among others. The core segments of the company include Salix, Solta Medical, Diversified, and Bausch + Lomb. Headquartered in Laval, Canada, the company is dedicated to becoming a globally integrated healthcare company that is trusted and valued by patients, investors, and employees.

In a world where one in eight population and one in five U.S. adults fight an invisible battle, the need for mental healthcare solutions is quite evident. Having said that, research co-led by Harvard Medical School and the University of Queensland shows that around 50% of the global population will win the battle against mental health challenges. Over some years, mental health-related solutions have gained significant popularity, and Bausch Health Companies (NYSE:BHC) is one of the few pharma companies facing an unprecedented market opportunity to shift the treatment paradigm for TRD (treatment-resistant depression), which is a $3 billion market in itself.

Although the company is under heavy debt and has a record of financial woes, the repositioning of Aplenzin for treating TRD can prove to have both clinical and financial opportunities. This reposition allows Bausch Health Companies Inc. (NYSE:BHC) to not only enhance the value of the drug and address an acute unmet need but also elevate revenues.

On that note, the management has expressed optimism regarding the future of Bausch Health Companies Inc. (NYSE:BHC), with a revenue guidance between $4.95 billion and $5.1 billion. The company is heavily focusing on growth through innovation, driven by its RED-C program and the potential success surrounding the Next Generation Fraxel device. Thus, for BHC, it is not the time to be on the sidelines of this ridiculously cheap stock.

Overall, BHC ranks first on our list of ridiculously cheap stocks to invest in. While we acknowledge the potential of cheap stocks, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than BHC but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9